Skip to main navigation Skip to search Skip to main content

Aptamer-Enabled Nanomaterials for Therapeutics, Drug Targeting and Imaging

  • Mengping Liu
  • , Lin Wang
  • , Young Lo
  • , Simon Chi-Chin Shiu
  • , Andrew B Kinghorn
  • , Julian A Tanner

Research output: Contribution to journalArticlepeer-review

85 Citations (Scopus)

Abstract

A wide variety of nanomaterials have emerged in recent years with advantageous properties for a plethora of therapeutic and diagnostic applications. Such applications include drug delivery, imaging, anti-cancer therapy and radiotherapy. There is a critical need for further components which can facilitate therapeutic targeting, augment their physicochemical properties, or broaden their theranostic applications. Aptamers are single-stranded nucleic acids which have been selected or evolved to bind specifically to molecules, surfaces, or cells. Aptamers can also act as direct biologic therapeutics, or in imaging and diagnostics. There is a rich field of discovery at the interdisciplinary interface between nanomaterials and aptamer science that has significant potential across biomedicine. Herein, we review recent progress in aptamer-enabled materials and discuss pending challenges for their future biomedical application.

Original languageEnglish
Article number159
Pages (from-to)1-33
JournalCells
Volume11
Issue number1
DOIs
Publication statusPublished - 4 Jan 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Aptamer-Enabled Nanomaterials for Therapeutics, Drug Targeting and Imaging'. Together they form a unique fingerprint.

Cite this